Clinical effect of Xuezhikang combined atorvastatin in treatment of patients with hypertension and coronary heart disease
Objective To analyze the clinical effect of Xuezhikang combined with atorvastatin in the treatment of hypertension with coronary heart disease. Methods 60 patients with hypertension and coronary heart disease who received and treated with atorvastatin alone from April 2016 to April 2017 in Longde County People's Hospital as the control group, and another 60 patients at the same time as the study group, they were given Xuezhikang combined with atorvastatin, compared the two groups of clinical treatment. Results The total effective rate of clinical treatment in control group (75.00%) was significantly lower than that in study group (93.33%). There was significant difference between the two groups (P<0.05). There was no significant difference in serum lipid levels between the two groups before treatment. After 4 weeks of treatment, there was no significant difference in high-density lipoprotein and total cholesterol between two groups. Levels of triglyceride and low density lipoprotein in study group were significantly lower than the control group, there was significant difference between the two groups (P<0.05). Conclusion It is possible to reduce the levels of serum lipids significantly, such as total cholesterol, triglyceride and low density lipoprotein, and improved the clinical curative effect in patients with hypertension complicated with coronary heart disease
NETL
NSTL
万方数据
维普
